Skip to main content

State Street Corp

SEC CIK
0000093751
Latest filing
Sep 22, 2026

CARM holding history

Carisma Therapeutics Inc. in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CARM overviewAll 13F holders of CARMFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of CARM by State Street Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−85,106−100.0%Sold outHolders
Q3 202585,106$23.3K<0.1%00.0%UnchangedHolders
Q2 202585,106$33.3K<0.1%00.0%UnchangedHolders
Q1 202585,106$26.4K<0.1%00.0%UnchangedHolders
Q4 202485,106$35.6K<0.1%00.0%UnchangedHolders
Q3 202485,106$83.5K<0.1%00.0%UnchangedHolders
Q2 202485,106$129.4K<0.1%−439,999−83.8%ReducedHolders
Q1 2024525,105$1.19M<0.1%+24,794+5.0%AddedHolders
Q4 2023500,311$1.47M<0.1%+18,192+3.8%AddedHolders
Q3 2023482,119$2.04M<0.1%+6,955+1.5%AddedHolders
Q2 2023475,164$4.17M<0.1%+441,821+1,325.1%AddedHolders
Q1 202333,343$103.4K<0.1%00.0%UnchangedConverted for a 1-for-20 splitHolders
Q4 2022666,962$406.5K<0.1%00.0%UnchangedHolders
Q3 2022666,962$283.0K<0.1%00.0%UnchangedHolders
Q2 2022666,962$541.0K<0.1%−3,672,070−84.6%ReducedHolders
Q1 20224,339,032$2.62M<0.1%+52,274+1.2%AddedHolders
Q4 20214,286,758$3.49M<0.1%+274,700+6.8%AddedHolders
Q3 20214,012,058$3.18M<0.1%−9,663,742−70.7%ReducedHolders
Q2 202113,675,800$63.2M<0.1%+13,558,500+11,558.8%AddedHolders
Q1 2021117,300$305.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.